Technology News and Research

RSS

Geisinger Health System acquires Renaissance from Mazor Robotics

Mazor Robotics Ltd, the leader in innovative surgical robots and complementary products for spine surgery, today announced that Geisinger Health System purchased its Renaissance system.

13 Sep 2012

Researchers hold new implications for pathogenesis of myotonic dystrophy

An important breakthrough could help in the fight against myotonic dystrophy. The discovery, recently published in the prestigious scientific journal Cell, results from an international collaboration between researchers at the IRCM, the Massachusetts Institute of Technology (MIT), the University of Southern California and Illumina.

13 Sep 2012

Local Talent Global Impact event at Queen's University to be held on Sep. 13

Members of the public are being invited to Queen's University at lunchtime on Thursday (13 September) to meet and hear from the people behind some of the biggest scientific, medical and technological breakthroughs of recent times.

13 Sep 2012

Incidence of Acute gastrointestinal illness is likely to rise in coming years

The distribution system piping in U.S. public water systems that rely on non-disinfected well water or "ground water" may be a largely unrecognized cause of up to 1.1 million annual cases of acute gastrointestinal illness (AGI), involving nausea, vomiting and diarrhea, scientists are reporting. Their study in ACS' journal Environmental Science & Technology concludes that such illnesses may become more of a problem as much of the nation's drinking water supply system continues to age and deteriorate.

13 Sep 2012

Predicting breast cancer drug response by 20/20 GeneSystems’ PredicTOR test

20/20 GeneSystems, Inc. will present results this week at the Breast Cancer Symposium 2012 (San Francisco) of a 45 patient study showing the usefulness of its PredicTOR test in predicting response of breast tumors to the drug Herceptin.

13 Sep 2012

LH Medical, Syneron Dental Lasers sign distribution agreement

Syneron Dental Lasers, the leading provider of innovative dental laser technologies announced today that it has signed a distribution agreement with LH Medical GmbH, a veteran distributor of cutting edge medical, dental and aesthetic products in Germany.

13 Sep 2012

Pathogens and Global Health highlights current debate on counterfeit medicine

The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.

13 Sep 2012

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

The Neurodegeneration Consortium (NDC), a transformative multi-institutional initiative, will advance the study and treatment of Alzheimer's and other neurodegenerative diseases, thanks to an inaugural $25 million gift from the Robert A. and Renee E. Belfer Family Foundation to The University of Texas MD Anderson Cancer Center, Baylor College of Medicine and the Massachusetts Institute of Technology (MIT).

13 Sep 2012

UWM, GE Healthcare partner to develop advanced medical imaging software

Combining industrial leadership and academic prowess, GE Healthcare and the University of Wisconsin-Milwaukee (UWM) today announced a unique collaboration aimed at building a pipeline of Wisconsin-based medical imaging software developers and researchers to drive the next generation of healthcare technology globally.

13 Sep 2012

Mayo Clinic ‘telestroke’ program will now be available at Casa Grande Regional Medical Center

Pinal County residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic "telestroke" program that will now be available at Casa Grande Regional Medical Center (CGRMC).

13 Sep 2012

Synthetic biology pioneer wins 2012 Heinz Award

Jay Keasling, a leading authority and pioneer on synthetic biology who has engineered microbial "factories" to manufacture an affordable version of a frontline antimalarial drug and biofuel substitutes for gasoline, diesel and jet fuel, has won a 2012 Heinz Award, which is presented by the Heinz Family Foundation and carries with it a cash prize of $250,000.

13 Sep 2012

Daily noise exposure can lead to permanent hearing loss in nightclub bar employees

New research shows that nightclub bar employees could be exposed to noise levels almost four times over the legal limit. Aoife Kelly, a PhD researcher in Dublin Institute of Technology also found that nightclub managers showed little awareness of the relevant health and safety legislation and had not provided hearing tests for their employees or provided training in noise awareness.

13 Sep 2012

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Pfizer Inc., the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, today announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd., a joint venture formed between the two companies to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

13 Sep 2012

Nano ‘velcro’ strip effective detector of water-borne contaminants

Researchers have developed a specialized glass strip covered in “hairy” nanoparticles that can detect pollution of water by toxic metals, such as mercury.

12 Sep 2012

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).

12 Sep 2012

Molecular beacons allow scientists to monitor gene expression during stem cell transformation

A novel set of custom-designed "molecular beacons" allows scientists to monitor gene expression in living populations of stem cells as they turn into a specific tissue in real-time. The technology, which Brown University researchers describe in a new study, provides tissue engineers with a potentially powerful tool to discover what it may take to make stem cells transform into desired tissue cells more often and more quickly.

12 Sep 2012

Children's Hospital Oakland to celebrate 100th birthday

Children's Hospital & Research Center Oakland is celebrating its 100th birthday. The free-standing, not-for-profit pediatric medical center was founded in 1912 and opened for business in 1914. Children's Hospital Oakland will celebrate the landmark birthday for two years and kicked off festivities with a birthday party at Children's Fairyland in Oakland on September 8.

12 Sep 2012

Facebook and other social media can enhance organ and tissue donation

When Facebook introduced a feature that enables people to register to become organ and tissue donors, thousands did so, dwarfing any previous donation initiative, write Blair L. Sadler and Alfred M. Sadler, Jr., in a commentary in Bioethics Forum, the blog of the Hastings Center Report, which analyzes the "Facebook effect" on donation.

12 Sep 2012

AusAID draft strategy includes more support for research into neglected diseases

The Australian Agency for International Development (AusAID) "is planning to boost support for medical research, technology and innovations," as well as "encourage collaboration and capacity building aimed at poverty-related and neglected tropical diseases," SciDev.Net reports.

12 Sep 2012

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

12 Sep 2012